|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 564.28 USD | -2.88% |
|
+2.42% | -5.05% |
| 12-10 | Axon Enterprise enters agreements with some holders - SEC filing | RE |
| 12-10 | Axon Enterprise Insider Sold Shares Worth $5,519,164, According to a Recent SEC Filing | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.35 | -6.85 | 2.71 | 3.12 | 1.22 | |||||
Return on Total Capital | 0.49 | -10.13 | 4.02 | 4.55 | 1.78 | |||||
Return On Equity % | -0.23 | -5.93 | 12.7 | 12.1 | 19.12 | |||||
Return on Common Equity | -0.23 | -5.93 | 12.7 | 12.1 | 19.12 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 61.13 | 62.65 | 61.23 | 61.11 | 59.64 | |||||
SG&A Margin | 42.14 | 59.65 | 33.89 | 31.27 | 34.74 | |||||
EBITDA Margin % | 2.73 | -17.31 | 10.33 | 12.14 | 6.02 | |||||
EBITA Margin % | 1.39 | -19.14 | 8.62 | 10.34 | 4.53 | |||||
EBIT Margin % | 0.9 | -19.47 | 8.28 | 10.05 | 3.69 | |||||
Income From Continuing Operations Margin % | -0.25 | -6.95 | 12.37 | 11.14 | 18.1 | |||||
Net Income Margin % | -0.25 | -6.95 | 12.37 | 11.14 | 18.1 | |||||
Net Avail. For Common Margin % | -0.25 | -6.95 | 12.37 | 11.14 | 18.1 | |||||
Normalized Net Income Margin | 1.09 | -11.91 | 5.4 | 7.96 | 3.5 | |||||
Levered Free Cash Flow Margin | -3.69 | 9.41 | 13.12 | 9.53 | 18.84 | |||||
Unlevered Free Cash Flow Margin | -3.68 | 9.41 | 13.13 | 9.61 | 19.05 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.56 | 0.52 | 0.5 | 0.53 | |||||
Fixed Assets Turnover | 7.52 | 5.96 | 6.43 | 7.03 | 7.88 | |||||
Receivables Turnover (Average Receivables) | 2.85 | 2.17 | 2.25 | 2.5 | 2.58 | |||||
Inventory Turnover (Average Inventory) | 4.11 | 3.25 | 2.97 | 2.57 | 3.14 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.83 | 2.65 | 3 | 3 | 2.3 | |||||
Quick Ratio | 3.34 | 2.26 | 2.54 | 2.52 | 1.91 | |||||
Operating Cash Flow to Current Liabilities | 0.15 | 0.3 | 0.39 | 0.24 | 0.41 | |||||
Days Sales Outstanding (Average Receivables) | 128.48 | 167.92 | 162.01 | 145.75 | 141.98 | |||||
Days Outstanding Inventory (Average Inventory) | 89.06 | 112.42 | 123.1 | 141.77 | 116.52 | |||||
Average Days Payable Outstanding | 28.98 | 30.15 | 30.29 | 40.06 | 30.17 | |||||
Cash Conversion Cycle (Average Days) | 188.55 | 250.19 | 254.82 | 247.46 | 228.33 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 2.5 | 2.57 | 56.56 | 44.69 | 31.41 | |||||
Total Debt / Total Capital | 2.44 | 2.51 | 36.13 | 30.89 | 23.9 | |||||
LT Debt/Equity | 1.94 | 1.95 | 56.06 | 44.08 | 31 | |||||
Long-Term Debt / Total Capital | 1.89 | 1.9 | 35.81 | 30.47 | 23.59 | |||||
Total Liabilities / Total Assets | 29.31 | 37.93 | 55.52 | 53.1 | 47.98 | |||||
EBIT / Interest Expense | 111.82 | -6K | 201.95 | 22.46 | 10.83 | |||||
EBITDA / Interest Expense | 460.49 | -5.07K | 269.75 | 28.56 | 19.7 | |||||
(EBITDA - Capex) / Interest Expense | -860.04 | -6.85K | 155.4 | 20.03 | 8.6 | |||||
Total Debt / EBITDA | 0.96 | -0.19 | 5.45 | 3.61 | 5.23 | |||||
Net Debt / EBITDA | -21.23 | 2.93 | -1.95 | -3 | -1.83 | |||||
Total Debt / (EBITDA - Capex) | -0.52 | -0.14 | 9.46 | 5.14 | 11.97 | |||||
Net Debt / (EBITDA - Capex) | 11.36 | 2.17 | -3.39 | -4.28 | -4.18 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 28.28 | 26.78 | 37.82 | 31.38 | 33.44 | |||||
Gross Profit, 1 Yr. Growth % | 35.49 | 29.92 | 34.71 | 31.12 | 29.99 | |||||
EBITDA, 1 Yr. Growth % | 167.33 | 31.36K | -182.27 | 61.29 | -29.92 | |||||
EBITA, 1 Yr. Growth % | -1.16K | 1.61K | -162.07 | 66.15 | -42.51 | |||||
EBIT, 1 Yr. Growth % | -239.96 | 1.2K | -158.62 | 68.45 | -51.8 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -295.46 | 3.38K | -345.16 | 18.41 | 114.49 | |||||
Net Income, 1 Yr. Growth % | -295.46 | 3.38K | -345.16 | 18.41 | 114.49 | |||||
Normalized Net Income, 1 Yr. Growth % | 192.6 | 3.13K | -162.51 | 104.12 | -42.12 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -400 | 2.93K | -323.08 | 13.79 | 106.01 | |||||
Accounts Receivable, 1 Yr. Growth % | 58.47 | 70.99 | 10.74 | 24.93 | 30.75 | |||||
Inventory, 1 Yr. Growth % | 131.58 | 20.82 | 86.29 | 33.28 | -1.68 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 139.23 | 26.54 | 28.74 | 13.68 | 23.32 | |||||
Total Assets, 1 Yr. Growth % | 63.31 | 22.24 | 68.93 | 20.51 | 31.25 | |||||
Tangible Book Value, 1 Yr. Growth % | 86.19 | 5.01 | 22.51 | 26.68 | -9.27 | |||||
Common Equity, 1 Yr. Growth % | 79.63 | 7.33 | 21.06 | 27.08 | 44.06 | |||||
Cash From Operations, 1 Yr. Growth % | -41.41 | 223.52 | 89.05 | -19.59 | 115.74 | |||||
Capital Expenditures, 1 Yr. Growth % | 355.67 | -31.31 | 11.86 | 6.87 | 32.11 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -154.05 | -319.25 | 92.15 | -2.48 | 288.01 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -153.94 | -319.5 | 92.24 | -1.73 | 276.13 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 27.33 | 27.53 | 32.19 | 34.57 | 32.45 | |||||
Gross Profit, 2 Yr. CAGR % | 26.89 | 32.68 | 32.29 | 32.9 | 30.78 | |||||
EBITDA, 2 Yr. CAGR % | -29.48 | 363.12 | 1.51K | 12.68 | 3.88 | |||||
EBITA, 2 Yr. CAGR % | -46.11 | 1.26K | 225.99 | -1.11 | -1.41 | |||||
EBIT, 2 Yr. CAGR % | -52.13 | 518.56 | 175.87 | -3.34 | -9.08 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -75.7 | 724.91 | 823.84 | 70.38 | 60.19 | |||||
Net Income, 2 Yr. CAGR % | -75.7 | 724.91 | 823.84 | 70.38 | 60.19 | |||||
Normalized Net Income, 2 Yr. CAGR % | -37.1 | 535.7 | 349.4 | 18.67 | -22.92 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -75.51 | 853.94 | 722.6 | 59.33 | 53.77 | |||||
Accounts Receivable, 2 Yr. CAGR % | 42.41 | 64.61 | 37.61 | 17.62 | 28.42 | |||||
Inventory, 2 Yr. CAGR % | 63.23 | 67.27 | 50.02 | 57.57 | 14.47 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 83.65 | 73.99 | 27.64 | 20.98 | 18.4 | |||||
Total Assets, 2 Yr. CAGR % | 38.54 | 41.29 | 43.7 | 42.68 | 25.26 | |||||
Tangible Book Value, 2 Yr. CAGR % | 48.6 | 39.83 | 13.42 | 24.58 | 7.34 | |||||
Common Equity, 2 Yr. CAGR % | 44.53 | 38.85 | 13.99 | 24.03 | 35.46 | |||||
Cash From Operations, 2 Yr. CAGR % | -22.38 | 37.68 | 147.31 | 23.3 | 31.71 | |||||
Capital Expenditures, 2 Yr. CAGR % | 155.35 | 76.91 | -12.35 | 9.34 | 18.82 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 57.49 | 32.18 | 105.35 | 35.42 | 60.77 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 57.38 | 32.19 | 105.42 | 35.98 | 61.68 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 25.59 | 27.14 | 30.87 | 31.92 | 34.11 | |||||
Gross Profit, 3 Yr. CAGR % | 26.21 | 27.89 | 33.35 | 31.9 | 31.93 | |||||
EBITDA, 3 Yr. CAGR % | -5.49 | 58.6 | 160.34 | 636.45 | -5.71 | |||||
EBITA, 3 Yr. CAGR % | -20.38 | 71.88 | 385.89 | 155.84 | -17.07 | |||||
EBIT, 3 Yr. CAGR % | -24.02 | 84.34 | 182.01 | 129.77 | -22.97 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -30.82 | 27.14 | 450.49 | 365.79 | 84.52 | |||||
Net Income, 3 Yr. CAGR % | -30.82 | 27.14 | 450.49 | 365.79 | 84.52 | |||||
Normalized Net Income, 3 Yr. CAGR % | -10.77 | 76.13 | 193.42 | 239.43 | -6.22 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -32.78 | 22.09 | 487.71 | 325.43 | 74.07 | |||||
Accounts Receivable, 3 Yr. CAGR % | 73.57 | 51.36 | 44.24 | 33.24 | 22.24 | |||||
Inventory, 3 Yr. CAGR % | 25.54 | 47.65 | 73.38 | 44.22 | 34.65 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 60.05 | 62.21 | 57.37 | 22.8 | 21.75 | |||||
Total Assets, 3 Yr. CAGR % | 59.85 | 32.88 | 49.96 | 35.51 | 38.39 | |||||
Tangible Book Value, 3 Yr. CAGR % | 91.68 | 32.36 | 33.8 | 17.68 | 12.17 | |||||
Common Equity, 3 Yr. CAGR % | 79.98 | 30.89 | 32.65 | 18.2 | 30.48 | |||||
Cash From Operations, 3 Yr. CAGR % | 27.72 | 24.91 | 53.03 | 70.06 | 48.58 | |||||
Capital Expenditures, 3 Yr. CAGR % | 91.03 | 64.83 | 51.84 | -6.36 | 16.45 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 16.66 | 100.18 | 49.73 | 59.07 | 69.01 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.61 | 100.2 | 49.77 | 59.51 | 69.64 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 28.04 | 26.34 | 28.19 | 30.06 | 31.44 | |||||
Gross Profit, 5 Yr. CAGR % | 26.48 | 25.97 | 28.61 | 29.87 | 32.23 | |||||
EBITDA, 5 Yr. CAGR % | -13.57 | 33.3 | 40.99 | 38.33 | 78.22 | |||||
EBITA, 5 Yr. CAGR % | -23.53 | 38.22 | 40.51 | 37.78 | 153.86 | |||||
EBIT, 5 Yr. CAGR % | -29.51 | 39.48 | 47.7 | 42.39 | 77.24 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -38.71 | 28.25 | 95.09 | 42.93 | 235.88 | |||||
Net Income, 5 Yr. CAGR % | -38.71 | 28.25 | 95.09 | 42.93 | 235.88 | |||||
Normalized Net Income, 5 Yr. CAGR % | -19.56 | 39.18 | 43.73 | 45.91 | 95.62 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -39.16 | 23.25 | 83.06 | 35.81 | 243.75 | |||||
Accounts Receivable, 5 Yr. CAGR % | 60.29 | 66.25 | 58.17 | 36.84 | 37.69 | |||||
Inventory, 5 Yr. CAGR % | 41.67 | 25.55 | 34.81 | 51.54 | 46.85 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 42.37 | 46.45 | 46.2 | 44.25 | 40.44 | |||||
Total Assets, 5 Yr. CAGR % | 43.13 | 43.43 | 53.18 | 36.72 | 39.54 | |||||
Tangible Book Value, 5 Yr. CAGR % | 46.44 | 51.18 | 55.39 | 29.19 | 22.51 | |||||
Common Equity, 5 Yr. CAGR % | 44.12 | 47.34 | 49.93 | 28.1 | 33.77 | |||||
Cash From Operations, 5 Yr. CAGR % | -3.69 | 42.57 | 66.36 | 24.26 | 44.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | 64.64 | 58.69 | 39.88 | 39.87 | 37.66 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -5.97 | 23.88 | 58.07 | 71.22 | 53.19 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.02 | 23.89 | 58.09 | 71.5 | 53.53 |
- Stock Market
- Equities
- AXON Stock
- Financials Axon Enterprise, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















